Title: Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Journal: Bioorganic & medicinal chemistry letters 20100301
885518-75-2 | 4-Bromo-1H-indazol-6-ol | AA004CN4 | MFCD07781338
887407-52-5 | N-Succinimidyloxycarbonylpentadecyl Methanethiosulfonate | AA004DYR | MFCD04039678
88124-55-4 | Ethyl 2-(5-amino-1,3,4-thiadiazol-2-yl)acetate | AA004FFF | MFCD00620684
87412-89-3 | 4-Chloro-1,3-dimethyl-1h-pyrazolo[3,4-d]pyrimidine | AA004GBT | MFCD09901801
869802-58-4 | 9-(DIMETHYLAMINO)-3-(HEXAHYDRO-1H-AZEPIN-1-YL)PYRIDO[3' ,2':4,5]THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE | AA004HB8 | MFCD09970991
868394-58-5 | 3-[4-(Carboxymethyl)phenyl]benzoic acid | AA004INV | MFCD11974269
86770-74-3 | 1-Amino-3,6,9-trioxaundecanyl-11-ol | AA004JFT | MFCD01752874
876715-40-1 | 4-(1H-1,2,4-Triazol-5-yl)benzoic acid | AA004KEF | MFCD07643206
877681-12-4 | 5-(Trifluoromethoxy)benzoimidazol-2(3H)-one | AA004LAD | MFCD05663530
849035-72-9 | Piperazine,1-[4-chloro-2-(methylsulfonyl)phenyl]- | AA004M5Q | MFCD04037938